Korean J Obstet Gynecol.  2011 Apr;54(4):214-217. 10.5468/KJOG.2011.54.4.214.

Malignant pericardial effusion in carcinoma of the uterine cervix

• Kim MH
• Lee TH
• Lee CJ
• Kim HY
• Kim WG
• Kim SH

• KMID: 2013243
• DOI: http://doi.org/10.5468/KJOG.2011.54.4.214

Abstract

The occurrence of malignant pericardial effusion is rare in squamous cell carcinoma of the uterine cervix. Only six cases of antemortem diagnosis have been reported. We report a patient with squamous cell carcinoma of the cervix who received emergent pericardiocentesis. In a few reported cases, women with pericardial involvement are candidates for radiation or chemotherapy. Early detection and prompt management of pericardial effusion is correlated with better quality of life and a decreased morbidity.

Keyword

Pericardial effusion; Squamous cell carcinoma of uterine cervix; Pericardiocentesis

MeSH Terms

Carcinoma, Squamous Cell
Cervix Uteri
Female
Humans
Pericardial Effusion
Pericardiocentesis
Quality of Life

Figure

• 

  Fig. 1 Pericardial effusion before pericardiocentesis (A) and after pericardiocentesis (B).

• 

  Fig. 2 Pericardial effusion (arrow) on parasternal long-axis view (A) and apical four-chamber view (B).

• 

  Fig. 3 A few clusters of anaplastic squamous cells seen in the pericardial fluid (H&E, ×100).

Reference

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008. 58:71–96.

2. Lockwood WB, Broghamer WL Jr. The changing prevalence of secondary cardiac neoplasms as related to cancer therapy. Cancer. 1980. 45:2659–2662.

3. Hayashi Y, Iwasaka T, Hachisuga T, Kishikawa T, Ikeda N, Sugimori H. Malignant pericardial effusion in endometrial adenocarcinoma. Gynecol Oncol. 1988. 29:234–239.

4. Nelson BE, Rose PG. Malignant pericardial effusion from squamous cell cancer of the cervix. J Surg Oncol. 1993. 52:203–206.

5. Rieke JW, Kapp DS. Successful management of malignant pericardial effusion in metastatic squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1988. 31:338–351.

6. Kralstein J, Frishman WH. Malignant pericardial diseases: diagnosis and treatment. Cardiol Clin. 1987. 5:583–589.

7. Hankins JR, Satterfield JR, Aisner J, Wiernik PH, McLaughlin JS. Pericardial window for malignant pericardial effusion. Ann Thorac Surg. 1980. 30:465–471.

8. Celermajer DS, Boyer MJ, Bailey BP, Tattersall MH. Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients. Med J Aust. 1991. 154:19–22.

9. Shepherd FA, Morgan C, Evans WK, Ginsberg JF, Watt D, Murphy K. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol. 1987. 60:1161–1166.

10. Shepherd FA, Ginsberg JS, Evans WK, Scott JG, Oleksiuk F. Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol. 1985. 3:1678–1682.

11. Thigpen T, Vance RB, Balducci L, Blessing J. Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma. Cancer. 1981. 48:2 Suppl. 658–665.

12. Choo YC. Chemotherapy in advanced primary and recurrent cervical carcinoma. Int J Gynaecol Obstet. 1982. 20:417–423.

13. Davis S, Rambotti P, Grignani F. Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases. J Clin Oncol. 1984. 2:631–636.

14. Cham WC, Freiman AH, Carstens PH, Chu FC. Radiation therapy of cardiac and pericardial metastases. Radiology. 1975. 114:701–704.

15. Jamshed A, Khafaga Y, El-Husseiny G, Gray AJ, Manji M. Pericardial metastasis in carcinoma of the uterine cervix. Gynecol Oncol. 1996. 61:451–453.